About mhf-admin

This author has not yet filled in any details.
So far mhf-admin has created 4 blog entries.

More Could Benefit from HIV Prevention Pill Truvada

Too few Americans who are at risk for HIV infection are taking Truvada — a daily pill that could protect them against the virus that causes AIDS, federal health officials report.

Health care providers must help boost patient awareness and use of the drug, health experts stressed.

About 25 percent of sexually active gay and bisexual adult men, 20 percent of injection drug users, and less than 1 percent of sexually active heterosexuals are at high risk for HIV infection, according to the U.S. Centers for Disease Control and Prevention’s Vital Signs report. People in these groups need to know about Truvada, which is also known as the pre-exposure prophylaxis (PrEP) pill, the government experts said.

Taken daily, the PrEP pill can reduce the risk of sexually acquired HIV by more than 90 percent. The PrEP pill can reduce injection drug users’ risk of HIV by more than 70 percent, the experts said.

However, recent data suggests some primary care health providers have never heard of PrEP, which was approved by the U.S. Food and Drug Administration in 2012. The full potential of the drug to prevent HIV infections can only be achieved by increasing awareness of the drug and providing counseling for those

December 10th, 2015|Categories: Men's Health, Research|

PrEP Research Study

The Men’s Health Foundation is conducting an investigator sponsored research study, “PUMP” ( PrEP in Urban Medical Primary Care).  It is a non-randomized, unblinded, retrospective and prospective analysis of  PrEP.  (The Southern California Men’s Medical Group, the clinical arm of Men’s Health Foundation, is one of the largest private prescribers of Truvada for PrEP in the US). The study goal is to evaluate real world retrospective and prospective PrEP data in a high capacity, urban primary and specialty care clinic of 300 MSM patients prescribed PrEP.

The Men’s Health Foundation has received funding to conduct a research study regarding PrEP. While the effectiveness of PrEP is no longer an issue to dispute, there is still a need for more data. Because most of the information that we have about PrEP comes from highly controlled and closely monitored clinical trials, it’s necessary to collect data about how PrEP will work in a real-world setting. The Men’s Health Foundation will be conducting a two-part PrEP study, which will include retrospective and prospective data collection.

The retrospective PrEP study will evaluate the outcomes of up to 300 past clinic patients who were prescribed PrEP. The study will seek information about how patients took PrEP, whether

July 13th, 2015|Categories: PrEP, Research|

Upcoming Gay Men’s Health Summits

The Men’s Health Foundation is hosting the “The Long Beach Gay Men’s Health Summit 2015” on Saturday, October 17 at the Courtyard Marriott in Downtown Long Beach with community partners. The fun event will feature interactive breakouts, a free lunch plenary on high-impact prevention, on site PrEP enrollment, counseling and entertainment, as well as prizes.

July 10th, 2015|Categories: Health Summit, Men's Health|

Pre-Exposure Prophylaxis (PrEP): Is It Right For Me?

With new research findings confirming its effectiveness, it is almost universally understood that PrEP is an exciting tool for HIV prevention. The decision to take PrEP, however, is not one to make lightly. Read on to learn more about PrEP.

July 10th, 2015|Categories: PrEP|